Bar Sezer, Kara Mehmet
Department of Medical Biochemistry, Medicine Faculty of Karabük University, 78000 Karabük, Turkey.
Exp Ther Med. 2024 Jul 9;28(3):359. doi: 10.3892/etm.2024.12648. eCollection 2024 Sep.
Diabetes mellitus (DM) is a prevalent metabolic disorder often accompanied by oxidative stress, which contributes to various diabetic complications. Investigating the antioxidant activity of linalool (LIN) is crucial as it may offer a natural therapeutic approach to mitigate oxidative damage in DM. The aim of the present study was to investigate the antioxidant activity of LIN in a DM rat model. A total of 40 male Wistar albino rats (age, 8 weeks; weight, 250-300 g) were used. CONTROL and DM groups were administered physiological saline solution by oral gavage for 21 days. In rats in the DM + LIN and LIN groups, 100 mg/kg LIN was administered intragastrically after streptozotocin injection (n=10 per group). In the first (48 h after STZ injection), second (1 week later), third (2 weeks later), and fourth (3 weeks later) blood glucose measurements, a statistically significant increase was found in the blood glucose values of the DM and DM + LIN groups compared with those of the CONTROL group. During the 21-day experimental period, there was no reduction in blood glucose levels of the DM + LIN group. Consequently, no discernible anti-hyperglycemic effect of LIN was observed. Catalase enzyme activity, superoxide dismutase (SOD) enzyme activity, malondialdehyde (MDA) levels and glutathione (GSH) levels were measured spectrophotometrically. All assays were conducted according to the protocols provided in the respective kits. The results were analyzed to assess the oxidative status and antioxidant capacity in the experimental groups. Catalase (CAT) activity was decreased in the DM group compared with that in the CONTROL group in both the serum and liver. However, LIN administration restored CAT activity in the DM + LIN group to the level of the CONTROL group. In the liver, the DM + LIN-treated group showed a notable reduction in malondialdehyde (MDA) levels compared with those in the DM group. In conclusion, the present results suggest that the antioxidant properties of LIN may have a regulatory effect on the oxidative status in diabetes-affected systems, potentially offering therapeutic benefits in managing oxidative stress associated with diabetes.
糖尿病(DM)是一种常见的代谢紊乱疾病,常伴有氧化应激,这会导致各种糖尿病并发症。研究芳樟醇(LIN)的抗氧化活性至关重要,因为它可能提供一种天然治疗方法来减轻糖尿病中的氧化损伤。本研究的目的是在糖尿病大鼠模型中研究LIN的抗氧化活性。总共使用了40只雄性Wistar白化大鼠(年龄8周;体重250 - 300克)。对照组和糖尿病组通过口服灌胃给予生理盐水溶液,持续21天。在糖尿病 + LIN组和LIN组的大鼠中,链脲佐菌素注射后经胃内给予100毫克/千克LIN(每组n = 10)。在首次(链脲佐菌素注射后48小时)、第二次(1周后)、第三次(2周后)和第四次(3周后)血糖测量中,发现糖尿病组和糖尿病 + LIN组的血糖值与对照组相比有统计学上的显著升高。在21天的实验期内,糖尿病 + LIN组的血糖水平没有降低。因此,未观察到LIN有明显的降血糖作用。采用分光光度法测量过氧化氢酶活性、超氧化物歧化酶(SOD)活性、丙二醛(MDA)水平和谷胱甘肽(GSH)水平。所有测定均按照各自试剂盒中提供的方案进行。对结果进行分析以评估实验组的氧化状态和抗氧化能力。糖尿病组血清和肝脏中的过氧化氢酶(CAT)活性与对照组相比均降低。然而,给予LIN使糖尿病 + LIN组的CAT活性恢复到对照组水平。在肝脏中,糖尿病 + LIN治疗组的丙二醛(MDA)水平与糖尿病组相比显著降低。总之,目前的结果表明,LIN的抗氧化特性可能对糖尿病影响的系统中的氧化状态具有调节作用,可能在管理与糖尿病相关的氧化应激方面提供治疗益处。